
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1057 | 1050 | 1109 | 1116 | 1223 | 1899 |
Fund Return | 5.66% | 5.01% | 10.93% | 3.72% | 4.11% | 6.62% |
Place in category | 66 | 241 | 248 | 174 | 149 | 69 |
% in Category | 15 | 62 | 70 | 56 | 51 | 29 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
FC Responsible Global Equity 1 Acc | 1.09B | 13.07 | 1.31 | 10.91 | ||
FC Responsible Global Equity 1 Inc | 1.09B | 4.50 | 5.84 | 10.91 | ||
FC Responsible Global Equity 2 Acc | 1.09B | 13.95 | 2.10 | 11.83 | ||
FC Responsible Global Equity 4 Inc | 1.09B | 14.76 | 2.83 | 12.59 | ||
FC Responsible Global Equity Fund 2 | 1.09B | -8.28 | 1.74 | 9.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Artemis UK Select Fund I Acc | 1.88B | 0.90 | 12.67 | 9.00 | ||
Artemis UK Select Fund G Inc GBP | 753.69M | 5.79 | 13.25 | - | ||
Artemis UK Select Fund R Acc | 211.31M | 5.69 | 12.10 | 9.10 | ||
Artemis UK Select Fund I Inc GBP | 219.59M | 25.31 | 10.43 | 9.44 | ||
Fidelity Special Situations Fund W | 3.11B | 1.22 | 8.90 | 6.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.32 | 10,300.0 | -0.19% | |
Unilever | GB00B10RZP78 | 4.96 | 54.84 | +0.55% | |
HSBC | GB0005405286 | 3.61 | 781.60 | +1.39% | |
Relx | GB00B2B0DG97 | 3.45 | 3,876.00 | +2.49% | |
Compass | GB00BD6K4575 | 3.16 | 2,549.00 | +1.11% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Strong Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Sell |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review